Grant R. Seeger

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Harpreet Wasan, Navesh Sharma, Volker Heinemann et al. · The Lancet Oncology · 2017 · 398 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Wisconsin Ginseng (Panax quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind Trial, N07C2

D. L. Barton, H. Liu, S. R. Dakhil et al. · JNCI Journal of the National Cancer Institute · 2013 · 297 citations · Full text

Medicine, Oncology, Pharmacology +2

Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies

Volker Heinemann, Navesh Sharma, Jens Ricke et al. · Clinical Colorectal Cancer · 2018 · 68 citations

Medicine, Oncology, Radiation Oncology +17

N08C9 (Alliance): A Phase 3 Randomized Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy

Robert C. Miller, Daniel G. Petereit, Jeff A. Sloan et al. · International Journal of Radiation Oncology*Biology*Physics · 2016 · 21 citations

Medicine, Pharmacology, Radiation Oncology +14